Alchemist vs Marathon Which Is More Profitable?

Alchemist and Marathon stocks are two well-known companies in the financial world that represent different investment strategies. The Alchemist stock is often associated with alchemy, embodying the idea of turning base metals into gold, symbolizing the potential for high returns. On the other hand, Marathon stock is named after the long-distance race, representing a steady and patient approach to investing for long-term growth. Both stocks offer unique opportunities and risks for investors seeking to grow their wealth in the ever-changing market landscape.

Alchemist or Marathon?

When comparing Alchemist and Marathon, different investors may prioritize various metrics based on their investment strategies and goals. So, ask yourself what type of investor you are. This will guide you in determining which metrics are most important for your investment decision between Alchemist and Marathon.

Dividend Investors:

Dividend investors look for stable and growing income streams, using dividend metrics to assess potential investments. A company's dividend yield essentially measures the size of its dividend relative to the total market value of the company. Alchemist has a dividend yield of -%, while Marathon has a dividend yield of -%. Beyond the yield itself, considering the growth and sustainability of these dividends is also crucial. Alchemist reports a 5-year dividend growth of 0.00% year and a payout ratio of 0.00%. On the other hand, Marathon reports a 5-year dividend growth of 0.00% year and a payout ratio of 0.00%.

Value Investors:

Value investors focus on financial metrics to determine a stock's intrinsic value compared to its market value. The Price-to-Earnings (P/E) Ratio links stock price to a company's earnings per share, with Alchemist P/E ratio at 158.75 and Marathon's P/E ratio at 0.00. Another crucial valuation metric is the Price-to-Book (P/B) Ratio, which compares stock price with book value per share. Alchemist P/B ratio is 0.72 while Marathon's P/B ratio is 0.00.

Growth Investors:

Growth investors prioritize metrics indicative of a company's expansion potential. Focusing on top-line growth, Alchemist has seen a 5-year revenue growth of 0.20%, while Marathon's is 0.00%. Return on Equity (ROE) measures how effectively a company uses equity investment to generate earnings, with Alchemist's ROE at 0.46% and Marathon's ROE at 0.00%.

Retail Investors:

Retail investors often consider stock affordability and company familiarity. For example, day low prices are ₹22.60 for Alchemist and $0.00 for Marathon. Over the past year, Alchemist's prices ranged from ₹4.43 to ₹22.60, with a yearly change of 410.16%. Marathon's prices fluctuated between $0.00 and $0.00, with a yearly change of 9900.00%. Brand recognition also plays a role, as familiarity with a company can influence investment decisions.